Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Volixibat

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mirum Pharma to Showcase Livmarli & Volixibat Data at AASLD
    Mirum Pharma to Showcase Livmarli & Volixibat Data at AASLD

    14 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241114053418/en

    BUSINESSWIRE
    14 Nov 2024
    Share Share
    Mirum’s Volixibat Achieves Positive Interim Analyses In VANTAGE PBC
    Mirum’s Volixibat Achieves Positive Interim Analyses In VANTAGE PBC

    17 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240617178174/en

    BUSINESSWIRE
    17 Jun 2024
    Share Share
    Mirum To Host Call On Volixibat VANTAGE VISTAS Interim Analysis
    Mirum To Host Call On Volixibat VANTAGE VISTAS Interim Analysis

    16 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240616032628/en

    BUSINESSWIRE
    16 Jun 2024
    Share Share
    Mirum Pharma to Showcase Analyses From Its Rare Liver Disease Programs at ILC
    Mirum Pharma to Showcase Analyses From Its Rare Liver Disease Programs at ILC

    16 Jun 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210616005316/en/Mirum-Pharmaceuticals-to-Showcase-Analyses-From-Its-Rare-Liver-Disease-Programs-at-The-International-Liver-Congress-2021

    BUSINESSWIRE
    16 Jun 2021
    Share Share
    Mirum spells out plans to turn Shire discards into orphan liver drug successes
    Mirum spells out plans to turn Shire discards into orphan liver drug successes

    24 Jun 2019

    // Amber Tong ENDPTS

    https://endpts.com/in-86m-ipo-pitch-mirum-spells-out-plans-to-turn-shire-discards-into-orphan-liver-drug-successes/

    Amber Tong ENDPTS
    24 Jun 2019
    Share Share
    Mirum Pharmaceuticals Secures $120 Million in Series A Financing to Develop Phase 3-Ready Maralixibat for Rare Liver Diseases
    Mirum Pharmaceuticals Secures $120 Million in Series A Financing to Develop Phase 3-Ready Maralixibat for Rare Liver Diseases

    07 Nov 2018

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mirum-pharmaceuticals-secures-120-million-in-series-a-financing-to-develop-phase-3-ready-maralixibat-for-rare-liver-diseases-300745243.html

    PR NEWSWIRE
    07 Nov 2018
    Share Share